Results 1 to 10 of about 155,831 (331)

Prognostic characteristics and recurrence patterns of grade 1 endometrial carcinoma: a large retrospective analysis of a tertiary center. [PDF]

Transl Cancer Res
Sadeghi N, Conforti J, Zouridis A, Kashif A, Darwish A, Smyth SL, Sattar A, Addley S, Pappa C, Damato S, Abdalla M, Kehoe S, Ferrari F, Soleymani Majd H.   +13 more
europepmc   +2 more sources

Study of ER, PR and VEGF Expression in Endometrial Epithelial Neoplasms and its Association with Histological Stage and Grade of Endometrial Carcinoma [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: Exogenous or endogenous oestrogen induces hyperplastic endometrium which presents with abnormal uterine bleeding. Atypical endometrial hyperplasia is the precursor for endometrial carcinoma. In case of invasive carcinoma, oestrogen Receptor
SK Samim Rahaman, Rathin Hazra, Nirmalya Chakrabarti, Prasenjit Kumar Bar   +3 more
doaj   +1 more source

lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression

Open Medicine, 2021
Zinc finger nuclear transcription factor, X-box binding 1-type containing 1 antisense RNA 1 (ZFAS1) functions as an oncogenic long noncoding RNA (lncRNA) to promote proliferation and metastasis of endometrial carcinoma cell; however, the underlying ...
Zhu Hongli, Cheng Qihui, Cai Hong
doaj   +1 more source

A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth

Cell Death and Disease, 2023
Exploring novel molecularly-targeted therapies for endometrial carcinoma is important. The current study explored the potential anti-endometrial carcinoma activity by a first-in-class POLRMT (RNA polymerase mitochondrial) inhibitor IMT1.
Shu-ping Li, Li Ou, Yan Zhang, Fang-rong Shen, You-guo Chen   +4 more
doaj   +1 more source

The Expression and Clinical Significance of Sphingosine Kinase 1 and Vascular Endothelial Growth Factor in Endometrial Carcinoma

Emergency Medicine International, 2022
The aim of the study is to investigate the expression of sphingosine kinase 1 (SPHK1) and vascular endothelial growth factor (VEGF) in patients with endometrial carcinoma and its clinical significance. The tissues of 86 cases of patients with endometrial
Hong Yu, null Dejizhuoga, Wei Huang, Donglian Wang, null Gamaquzhen, Xiaomin Jia, Hao Feng   +6 more
doaj   +1 more source

Variants of in situ carcinoma of the endometrium: Clear cell and gastrointestinal types, with a review of the literature

Gynecologic Oncology Reports, 2022
Two precursor lesions are commonly associated with endometrial carcinoma. Atypical endometrial hyperplasia/endometrial intraepithelial neoplasia is a known precursor lesion of endometrial endometrioid carcinoma, while endometrial intraepithelial ...
Evi Abada, Natalie Banet, M. Ruhul Quddus   +2 more
doaj   +1 more source

Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma

Journal of Genetic Engineering and Biotechnology, 2021
Background Livin/BIRC7 is a member of the inhibitors of apoptosis proteins family which are implicated in development of cancer through the inhibition of apoptosis process.
Basma K. Elmekkawy, Rasha M. S. Shoaib, Amal K. Seleem, Dalia Shalaan, Entsar A. Saad   +4 more
doaj   +1 more source

A Potential Invasion-Promoting Role for Ezrin in Endometrial Carcinoma [PDF]

Research in Oncology, 2020
Background:Ezrin is a cell membrane-cytoskeleton linker that is essential to maintain the normal cell shape and the integrity of cell-cell adhesion. Overexpression of ezrin is correlated with poor prognosis in several malignancies.
Ahmed R. H. Ahmed, Ghada M. Yousef, Mohamed S. E. Abdel-Raheem, Eman M. S. Muhammad   +3 more
doaj   +1 more source

Postablation Endometrial Carcinoma [PDF]

JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2017
Many women have undergone both resectoscopic and nonresectoscopic (or global) endometrial ablation (EA) during the past 20 years. These women are now approaching their sixth and seventh decades of life, a time frame in which endometrial carcinoma (EC) is most frequently diagnosed.In several reports, surgeons have expressed concern that endometrial ...
Wortman, Morris, Vilos, George A., Vilos, Angelos G., Abu-Rafea, Basim, Dwyer, Wendy, Spitz, Robert   +5 more
openaire   +4 more sources

Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study.

PLoS ONE, 2022
ObjectivesThe strong association between atypical endometrial hyperplasia and endometrial carcinoma is well established, but data on the risk of atypical hyperplasia and carcinoma in Danish women with non-atypical endometrial hyperplasia are almost non ...
Clara M Prip, Maria Stentebjerg, Mary H Bennetsen, Lone K Petersen, Pinar Bor   +4 more
doaj   +3 more sources